Tan Lijie

Lijie Biotech, officially known as Suzhou Lijie Biopharmaceutical, is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company primarily targets high-unmet-need areas within oncology and immunology, leveraging its internal research capabilities to advance a pipeline of novel drug candidates. Headquartered in the Suzhou Industrial Park, Lijie Biotech aims to translate cutting-edge biological insights into effective clinical treatments. The firm is currently in the early stages of its development, with most programs residing in the pre-clinical phase.